Results 1 to 10 of about 10,606 (259)

Successful Impella 5.0 Catheter Removal in the Setting of Left Ventricular Thrombus With Use of the Sentinel Cerebral Protection Device [PDF]

Case Reports in Cardiology
Mechanical circulatory support devices, such as the Impella catheter (Abiomed, Danvers, Massachusetts), continue to become more commonplace in patients undergoing high-risk percutaneous coronary intervention (PCI) or those in cardiogenic shock.
Anne Sandstrom, Kristen Errico, Debanshu Roy, Andrea J. Carpenter, Anand Prasad   +4 more
doaj   +2 more sources

Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context. [PDF]

Cardiol Ther
Background: Cardiogenic shock (CS) is a life-threatening failure of the heart to supply adequate blood, requiring immediate treatment. Although nowadays Impella® heart pumps and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) are both widely
Rognoni C, Ardito V, La Fauci D, Pieri M, Scandroglio AM, Tarricone R.   +5 more
europepmc   +6 more sources

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock [PDF]

Open Heart, 2019
Objective We investigated the benefit of Impella, a modern percutaneous mechanical support (pMCS) device, versus former standard intra-aortic balloon pump (IABP) in acute myocardial infarction complicated by cardiogenic shock (AMICS).Methods This single ...
Ulf Landmesser, Brunilda Alushi, Andel Douedari, Georg Froehlig, Wulf Knie, Thomas H Wurster, David M Leistner, Barbara-Elisabeth Staehli, Hans-Christian Mochmann, Burkert Pieske, Florian Krackhardt, Carsten Skurk   +11 more
doaj   +2 more sources

A Review of Bleeding Risk with Impella-Supported High-Risk Percutaneous Coronary Intervention [PDF]

, 2020
Complex, high-risk percutaneous coronary intervention (HR-PCI) is increasingly being performed, often with mechanical circulatory support (MCS), though to date, there are limited randomised data on the efficacy of MCS for HR-PCI.
Dahle, Thom G, Kaki, Amir, Vetrovec, George W   +2 more
core   +4 more sources

TCT-482: A Prospective Multicenter Randomized Clinical Trial of Intra-aortic Balloon Pump vs Impella for Hemodynamic Support During High Risk PCI: Final Clinical and Angiographic Results of PROTECT II [PDF]

, 2011

core   +2 more sources

Protective effect of the Impella on the left ventricular function after acute broad anterior wall ST elevation myocardial infarctions with cardiogenic shock: cardiovascular magnetic resonance imaging strain analysis

BMC Cardiovascular Disorders, 2022
Background The clinical efficacy of the Impella for high-risk percutaneous coronary intervention (PCI) and cardiogenic shock remains under debate. We thus sought to investigate the protective effects on the heart with the Impella’s early use pre-PCI ...
Daisuke Fukamachi, Akimasa Yamada, Akihito Ohgaku, Yutaka Koyama, Hidesato Fujito, Riku Arai, Yasunari Ebuchi, Suguru Migita, Tomoyuki Morikawa, Masaki Monden, Norio Takei, Takehiro Tamaki, Keisuke Kojima, Naotaka Akutsu, Nobuhiro Murata, Yuki Saito, Daisuke Kitano, Mitsumasa Sudo, Yasuo Okumura   +18 more
doaj   +1 more source

Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery

Brazilian Journal of Cardiovascular Surgery, 2022
Introduction: The Impella ventricular support system is a device that can be inserted percutaneously or directly across the aortic valve to unload the left ventricle.
Serge Sicouri, Vishal N. Shah, Meghan Buckley, Nicholas Imperato, Jacqueline McGee, Elena Casanova, Eric Gnall, Konstadinos A. Plestis   +7 more
doaj   +1 more source

Outcome of Patients Supported by Large Impella Systems After Re-implantation Due to Continued or Recurrent Need of Temporary Mechanical Circulatory Support

Frontiers in Cardiovascular Medicine, 2022
Despite the growing utilization of a large microaxial pump, i. e., Impella 5.0 or 5.5 (Abiomed Inc., Danvers, MA, USA) (Impella 5+) for patients with cardiogenic shock (CS), adverse events including the necessity of re-implantation have not been well ...
Yukiharu Sugimura, Sebastian Bauer, Moritz Benjamin Immohr, Arash Mehdiani, Philipp Rellecke, Ralf Westenfeld, Hug Aubin, Udo Boeken, Artur Lichtenberg, Payam Akhyari   +9 more
doaj   +1 more source

Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy [PDF]

, 2016
No abstract ...
Arrigo, Biteker, Blauwet, Brignole, Burkhoff, Cecconi, Duncker, Elkayam, Ersbøll, Fett, Fett, Forster, Gevaert, Haghikia, Haghikia, Haghikia, Hilfiker-Kleiner, Hilfiker-Kleiner, Hilfiker-Kleiner, Hilfiker-Kleiner, Kao, Labbene, Levy, Maisch, Masip, McNamara, Mebazaa, Mebazaa, Miller, Mouquet, Napp, Neumann, O'Connor, Patten, Pillarisetti, Ponikowski, Rasmusson, Regitz-Zagrosek, Schroeter, Seyfarth, Slaughter, Sliwa, Sliwa, Sliwa, Stapel, Strueber, Thiele, Thiele, Tibazarwa   +48 more
core   +7 more sources

Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle

Intensive Care Medicine Experimental, 2020
Background and aim This study aimed to assess right ventricular (RV) function during cardiogenic shock due to acute left ventricular (LV) failure, including during LV unloading with Impella CP and an added moderate dose of norepinephrine.
Jakob Josiassen, Ole Kristian Lerche Helgestad, Nanne Louise Junker Udesen, Ann Banke, Peter Hartmund Frederiksen, Janus Adler Hyldebrandt, Henrik Schmidt, Lisette Okkels Jensen, Christian Hassager, Hanne Berg Ravn, Jacob E. Møller   +10 more
doaj   +1 more source